Energy-efficient and Health Promoting Light for Elderly People (light-age)

August 3, 2018 updated by: Line Kessel, Glostrup University Hospital, Copenhagen

A Study of Two Different Light Conditions for Healthy Subjects Above 65 Years

to investigate the effect of two lightning conditions on sleep hypothesizing that sleep length is influenced by the color of light during daytime

Study Overview

Status

Completed

Conditions

Intervention / Treatment

Detailed Description

Lightning conditions seems to be important for the length and quality of sleep, as light have an influence on the production of the sleep hormone (melatonin) and the the circadian rhythm. Entrainment of the circadian rhythm to the surroundings is accomplished by light-sensitive retinal ganglion cells and these cells are sensitive to blue light.

Based on previous research, blue light early in the day and abscence of blue light during evening is important for the entrainment.

In this study, lightning conditions in the home of healthy subjects are set to either blue enriched or red enriched from 8 a.m to 1. p.m. The lightning condition is based on a randomization protocol in a cross-over study for 3 weeks in each condition, separated by a one week pause.

Study Type

Interventional

Enrollment (Actual)

29

Phase

  • Not Applicable

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

65 years to 85 years (OLDER_ADULT)

Accepts Healthy Volunteers

Yes

Genders Eligible for Study

All

Description

Inclusion Criteria:

  • age 65 to 85 years

Exclusion Criteria:

  • Conditions which will interfere by the primary endpoint as evaluated by the medical doctor

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: BASIC_SCIENCE
  • Allocation: RANDOMIZED
  • Interventional Model: CROSSOVER
  • Masking: SINGLE

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
PLACEBO_COMPARATOR: red light
red light during the whole day
ACTIVE_COMPARATOR: Blue light
Blue light during early day

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Sleep length
Time Frame: 1 week
The mean of sleep length during the last week of each light period
1 week

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
actigraphy
Time Frame: 1 week
mean sleep efficiency during the last week in each light period
1 week

Other Outcome Measures

Outcome Measure
Measure Description
Time Frame
pupillometry
Time Frame: the last day of each light period
the pupillary response to blue and red light
the last day of each light period
melatonin
Time Frame: the last day of each light period
timing of melatonin onset
the last day of each light period
Questionnaire
Time Frame: 3 weeks
Questionnaire count
3 weeks

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: Line Kessel, MD, Glostrup University Hospital, Copenhagen

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start

October 1, 2013

Primary Completion (ACTUAL)

December 1, 2013

Study Completion (ACTUAL)

December 1, 2013

Study Registration Dates

First Submitted

August 12, 2014

First Submitted That Met QC Criteria

August 12, 2014

First Posted (ESTIMATE)

August 13, 2014

Study Record Updates

Last Update Posted (ACTUAL)

August 6, 2018

Last Update Submitted That Met QC Criteria

August 3, 2018

Last Verified

August 1, 2018

More Information

Terms related to this study

Other Study ID Numbers

  • H-3-2013-085

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Subscribe